Phase
Condition
Osteoporosis
Treatment
Alendronate 70mg weekly
Clinical Study ID
Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Female
Postmenopausal
Current treatment with Alendronate
Alendronate treatment >3 år AND no fracture OR
Alendronate treatment >5 år AND latest low energy fracture > 3 years ago
Exclusion
Exclusion Criteria:
T-score < - 3,5 in hip (total hip or femoral neck) or lumbar spine
Treatment with systemic glucocorticoids, ongoing or within 12 months
Uncontrolled inflammatory disease
Active malignancy
eGFR < 40 mL/min
Atypical femur fracture (ever)
OsteoNecrosis of the Jaw (active)
Unable to give inform consent
Study Design
Connect with a study center
Aalborg University Hospital
Aalborg, 9000
DenmarkSite Not Available
Bispebjerg Hospital
Copenhagen, 2400
DenmarkSite Not Available
Esbjerg Og Grindsted Sygehus
Esbjerg, 6700
DenmarkSite Not Available
Copenhagen University Hospital (Herlev)
Herlev, 2730
DenmarkSite Not Available
Nordsjaellands Hospital (Hillerød)
Hillerød, 3400
DenmarkSite Not Available
Hvidovre Hospital
Hvidovre, 2650
DenmarkSite Not Available
Odense University Hospital
Odense, 5000
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.